By Ahmed Eljechtimi
RABAT (Reuters) -U.S. pharmaceutical big Viatris Inc (NASDAQ:). has been fined 7.58 million dirhams ($760,000) by Morocco’s competitors regulator for failing to inform it relating to its merger, two official sources stated on Thursday.
Viatris was fashioned by the merger of Mylan, which has a subsidiary in Morocco, and Pfizer (NYSE:)’s Upjohn enterprise in 2020.
The positive, equal to 2.5% Viatris’ income in Morocco final 12 months, has already been paid to the Moroccan treasury, the sources stated, requesting anonymity.
Viatris additionally declined to attraction the choice, the sources stated.
Viatris didn’t instantly reply to a Reuters emailed request for remark.
The regulator can also be planning to look into different mergers during which the businesses didn’t notify the regulator. These may embody a three way partnership between the phosphates and fertilizers big OCP and Fertinagro Biotech and the takeover of Whirlpool (NYSE:) Center East and North Africa operations by Turkey’s home equipment maker Arcelik (IS:), one of many two sources stated.
OCP and Arcelik didn’t instantly reply to Reuters’ requests for remark.
